Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · IEX Real-Time Price · USD
3.090
-0.050 (-1.59%)
At close: May 17, 2024, 4:00 PM
3.080
-0.010 (-0.32%)
After-hours: May 17, 2024, 7:29 PM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $576.95 million as of May 17, 2024. Its market cap has increased by 1,168.02% in one year.
Market Cap
576.95M
Enterprise Value
509.38M
1-Year Change
1,168.02%
Ranking
Category
Stock Price
$3.09
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $576.95M, a decrease of -16.44%. That is a compound annual growth rate of -4.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 577.90M | -1.58% |
| May 16, 2024 | 587.20M | 0.96% |
| May 15, 2024 | 581.60M | 21.02% |
| May 14, 2024 | 480.60M | 7.09% |
| May 13, 2024 | 448.80M | 2.56% |
| May 10, 2024 | 437.60M | -7.52% |
| May 9, 2024 | 473.20M | 6.31% |
| May 8, 2024 | 445.10M | -4.03% |
| May 7, 2024 | 463.80M | -5.35% |
| May 6, 2024 | 490.00M | 1.96% |
| May 3, 2024 | 480.60M | -0.39% |
| May 2, 2024 | 482.50M | 6.61% |
| May 1, 2024 | 452.60M | -0.42% |
| Apr 30, 2024 | 454.50M | -0.81% |
| Apr 29, 2024 | 458.20M | 2.51% |
| Apr 26, 2024 | 447.00M | 3.93% |
| Apr 25, 2024 | 430.10M | -2.14% |
| Apr 24, 2024 | 439.50M | -7.12% |
| Apr 23, 2024 | 473.20M | 2.85% |
| Apr 22, 2024 | 460.10M | 8.39% |
| Apr 19, 2024 | 424.50M | -5.81% |
| Apr 18, 2024 | 450.70M | -1.64% |
| Apr 17, 2024 | 458.20M | -4.86% |
| Apr 16, 2024 | 481.60M | -3.20% |
| Apr 15, 2024 | 497.50M | -9.51% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calliditas Therapeutics AB (publ) | 588.25M |
| PetIQ | 584.95M |
| Mind Medicine (MindMed) | 583.75M |
| Accolade | 581.41M |
| Avid Bioservices | 577.35M |
| enGene Holdings | 572.88M |
| Altimmune | 566.15M |
| Nano-X Imaging | 565.66M |